Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Influenza

Free Subscription Articles published in Antiviral Res Retrieve available abstracts of 43 articles: HTML format

Single Articles

July 2009
1. HURT AC , Ernest J, Deng YM, Iannello P, et al
   Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
   Antiviral Res. 2009;83:90-3.
   PubMed     Related articles    Abstract available
   
   
   
2. YAMADA K , Ogawa H, Hara A, Yoshida Y, et al
   Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus.
   Antiviral Res. 2009;83:35-44.
   PubMed     Related articles    Abstract available
   
   
   May 2009
3. ASCIONE A , Capecchi B, Campitelli L, Imperiale V, et al
   Human monoclonal antibodies in single chain fragment variable format with potent neutralization activity against influenza virus H5N1.
   Antiviral Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   
4. WOLKERSTORFER A , Kurz H, Bachhofner N, Szolar O, et al
   Glycyrrhizin inhibits Influenza A virus uptake into the cell.
   Antiviral Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   April 2009
5. RUNGROTMONGKOL T , Frecer V, De-Eknamkul W, Hannongbua S, et al
   Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
   Antiviral Res. 2009;82:51-8.
   PubMed     Related articles    Abstract available
   
   
   
6. BAUER K , Richter M, Wutzler P, Schmidtke M, et al
   Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
   Antiviral Res. 2009;82:34-41.
   PubMed     Related articles    Abstract available
   
   
   
7. GUO L , Garten RJ, Foust AS, Sessions WM, et al
   Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR/restriction fragment length polymorphism assay.
   Antiviral Res. 2009;82:29-33.
   PubMed     Related articles    Abstract available
   
   
   March 2009
8. JANG YJ , Wang JH, Kim JS, Kwon HJ, et al
   Levocetirizine inhibits rhinovirus-induced ICAM-1 and cytokine expression and viral replication in airway epithelial cells.
   Antiviral Res. 2009;81:226-33.
   PubMed     Related articles    Abstract available
   
   
   February 2009
9. NAESENS L , Vanderlinden E, Roth E, Jeko J, et al
   Anti-influenza virus activity and structure-activity relationship of aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains.
   Antiviral Res. 2009.
   PubMed     Related articles    Abstract available
   
   
   January 2009
10. ROTH JP , Li JK, Smee DF, Morrey JD, et al
    A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays.
    Antiviral Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    
11. BARNARD DL
    Animal models for the study of influenza pathogenesis and therapy.
    Antiviral Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    
12. TAO P , Luo M, Pan R, Lin D, et al
    Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Antiviral Res. 2009.
    PubMed     Related articles    Abstract available
    
    
    
13. WAINBERG MA
    Perspectives on antiviral drug development.
    Antiviral Res. 2009;81:1-5.
    PubMed     Related articles    Abstract available
    
    
    December 2008
14. QIAO C , Jiang Y, Tian G, Wang X, et al
    Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus.
    Antiviral Res. 2008.
    PubMed     Related articles    Abstract available
    
    
    
15. YAMAZAKI Y , Ishii T, Honda A
    The influence of oseltamivir carboxylate and oseltamivir on hemagglutinin inhibition and microneutralization test.
    Antiviral Res. 2008;80:354-9.
    PubMed     Related articles    Abstract available
    
    
    November 2008
16. LENEVA IA , Russell RJ, Boriskin YS, Hay AJ, et al
    Characteristics of arbidol-resistant mutants of influenza virus: Implications for the mechanism of anti-influenza action of arbidol.
    Antiviral Res. 2008.
    PubMed     Related articles    Abstract available
    
    
    
17. HUNG HC , Tseng CP, Yang JM, Ju YW, et al
    Aurintricarboxylic acid inhibits influenza virus neuraminidase.
    Antiviral Res. 2008.
    PubMed     Related articles    Abstract available
    
    
    
18. CHEONG WS , Reiseger J, Turner SJ, Boyd R, et al
    Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.
    Antiviral Res. 2008.
    PubMed     Related articles    Abstract available
    
    
    October 2008
19. DEYDE VM , Okomo-Adhiambo M, Sheu TG, Wallis TR, et al
    Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses.
    Antiviral Res. 2008.
    PubMed     Related articles    Abstract available
    
    
    September 2008
20. SU CY , Wang SY, Shie JJ, Jeng KS, et al
    In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses.
    Antiviral Res. 2008;79:199-205.
    PubMed     Related articles    Abstract available
    
    
    July 2008
21. STITTELAAR KJ , Tisdale M, van Amerongen G, van Lavieren RF, et al
    Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in the cynomolgus macaques.
    Antiviral Res. 2008.
    PubMed     Related articles    Abstract available
    
    
    
22. BARR IG , Deng YM, Iannello P, Hurt AC, et al
    Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries.
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. SMEE DF , Bailey KW, Wong MH, O'Keefe BR, et al
    Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    June 2008
24. WANG R , Song A, Levin J, Dennis D, et al
    Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein.
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. BOLTZ DA , Ilyushina NA, Arnold CS, Babu YS, et al
    Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice.
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. HOFFMANN HH , Palese P, Shaw ML
    Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity.
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    May 2008
27. BASLER CF , Aguilar PV
    Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses.
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
28. AO Z , Patel A, Tran K, He X, et al
    Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules.
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
29. GILBERT BE , McLeay MT
    MegaRibavirin aerosol for the treatment of influenza A virus infections in mice.
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. BEIGEL J , Bray M
    Current and future antiviral therapy of severe seasonal and avian influenza.
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
31. NAKAZAWA M , Kadowaki SE, Watanabe I, Kadowaki Y, et al
    PA subunit of RNA polymerase as a promising target for anti-influenza virus agents.
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
32. PABBARAJU K , Ho KC, Wong S, Shokoples S, et al
    Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007).
    Antiviral Res. 2008;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
33. HIGGS ES , Hayden FG, Chotpitayasunondh T, Whitworth J, et al
    The Southeast Asian Influenza Clinical Research Network: Development and challenges for a new multilateral research endeavor.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    October 2007
34. MAO H , Thakur CS, Chattopadhyay S, Silverman RH, et al
    Inhibition of human parainfluenza virus type 3 infection by novel small molecules.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    September 2007
35. HE G , Qiao J, Dong C, He C, et al
    Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. ABED Y , Nehme B, Baz M, Boivin G, et al
    Activity of the neuraminidase inhibitor A-315675 against oseltamivir-resistant influenza neuraminidases of N1 and N2 subtypes.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
37. HO HT , Hurt AC, Mosse J, Barr I, et al
    Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. ZHOU H , Jin M, Yu Z, Xu X, et al
    Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. SONG JM , Park KD, Lee KH, Byun YH, et al
    Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    June 2007
40. EHRHARDT C , Hrincius ER, Korte V, Mazur I, et al
    A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
41. DROEBNER K , Ehrhardt C, Poetter A, Ludwig S, et al
    CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    April 2007
42. JIANG Y , Yu K, Zhang H, Zhang P, et al
    Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. BAUER K , Schrader C, Suess J, Wutzler P, et al
    Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.
    Antiviral Res. 2007;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

This E-mail is provided by AMEDEO through an unrestricted educational grant from www.InfluenzaWorld.com, a Roche service.

Amedeo is a Flying Publisher website.    Design: